HY-10015-25mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
HY-10015-5mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
HY-10015-50mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
HY-10015-1mL
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-P1208-1mg
|
MedChemexpress LLC
|
PG-931 [CAS 667430-81-1]
|
|
COVID-19-immunoregulation
|
|
HY-P1208-10mg
|
MedChemexpress LLC
|
PG-931 [CAS 667430-81-1]
|
|
COVID-19-immunoregulation
|
|
HY-P1208-5mg
|
MedChemexpress LLC
|
PG-931 [CAS 667430-81-1]
|
|
COVID-19-immunoregulation
|
|
HY-47888-10mg
|
MedChemexpress LLC
|
PLN-1474 [CAS 2408065-32-5]
|
|
COVID-19-immunoregulation
|
|
HY-47888-100mg
|
MedChemexpress LLC
|
PLN-1474 [CAS 2408065-32-5]
|
|
COVID-19-immunoregulation
|
|
HY-47888-25mg
|
MedChemexpress LLC
|
PLN-1474 [CAS 2408065-32-5]
|
|
COVID-19-immunoregulation
|
|
HY-47888-5mg
|
MedChemexpress LLC
|
PLN-1474 [CAS 2408065-32-5]
|
|
COVID-19-immunoregulation
|
|
HY-47888-50mg
|
MedChemexpress LLC
|
PLN-1474 [CAS 2408065-32-5]
|
|
COVID-19-immunoregulation
|
|
HY-D0815-10mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-D0815-100mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-D0815-5mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-D0815-50mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-D0815-500mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-11068-1mg
|
MedChemexpress LLC
|
SB 239063 [CAS 193551-21-2]
|
|
COVID-19-immunoregulation
|
|
HY-11068-10mg
|
MedChemexpress LLC
|
SB 239063 [CAS 193551-21-2]
|
|
COVID-19-immunoregulation
|
|
HY-11068-25mg
|
MedChemexpress LLC
|
SB 239063 [CAS 193551-21-2]
|
|
COVID-19-immunoregulation
|
|
HY-11068-5mg
|
MedChemexpress LLC
|
SB 239063 [CAS 193551-21-2]
|
|
COVID-19-immunoregulation
|
|
HY-11068-50mg
|
MedChemexpress LLC
|
SB 239063 [CAS 193551-21-2]
|
|
COVID-19-immunoregulation
|
|
HY-11068-1mL
|
MedChemexpress LLC
|
SB 239063 [CAS 193551-21-2] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-14973-10mg
|
MedChemexpress LLC
|
Vidupiprant [CAS 1169483-24-2]
|
|
COVID-19-immunoregulation
|
|
HY-14973-100mg
|
MedChemexpress LLC
|
Vidupiprant [CAS 1169483-24-2]
|
|
COVID-19-immunoregulation
|
|